- Home
- SUUN vs ELUT Comparison
SUUN vs ELUT Comparison
Compare SUUN & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUUN
- ELUT
- Stock Information
- Founded
- SUUN 2013
- ELUT 2015
- Country
- SUUN Canada
- ELUT United States
- Employees
- SUUN N/A
- ELUT N/A
- Industry
- SUUN
- ELUT Medical Specialities
- Sector
- SUUN
- ELUT Health Care
- Exchange
- SUUN Nasdaq
- ELUT Nasdaq
- Market Cap
- SUUN 75.1M
- ELUT 71.5M
- IPO Year
- SUUN N/A
- ELUT 2020
- Fundamental
- Price
- SUUN $1.50
- ELUT $2.11
- Analyst Decision
- SUUN Strong Buy
- ELUT Strong Buy
- Analyst Count
- SUUN 1
- ELUT 2
- Target Price
- SUUN $6.00
- ELUT $8.00
- AVG Volume (30 Days)
- SUUN 646.0K
- ELUT 27.0K
- Earning Date
- SUUN 08-14-2025
- ELUT 08-06-2025
- Dividend Yield
- SUUN N/A
- ELUT N/A
- EPS Growth
- SUUN N/A
- ELUT N/A
- EPS
- SUUN N/A
- ELUT N/A
- Revenue
- SUUN $25,798,969.00
- ELUT $23,711,000.00
- Revenue This Year
- SUUN $15.42
- ELUT $20.10
- Revenue Next Year
- SUUN $62.53
- ELUT $85.89
- P/E Ratio
- SUUN N/A
- ELUT N/A
- Revenue Growth
- SUUN N/A
- ELUT N/A
- 52 Week Low
- SUUN $1.23
- ELUT $1.61
- 52 Week High
- SUUN $6.43
- ELUT $5.24
- Technical
- Relative Strength Index (RSI)
- SUUN 43.83
- ELUT 49.75
- Support Level
- SUUN $1.36
- ELUT $1.70
- Resistance Level
- SUUN $1.84
- ELUT $1.99
- Average True Range (ATR)
- SUUN 0.14
- ELUT 0.14
- MACD
- SUUN 0.03
- ELUT 0.01
- Stochastic Oscillator
- SUUN 39.24
- ELUT 38.17
About SUUN SolarBank Corporation Common Stock
SolarBank Corp is an independent renewable and clean energy project developer and asset operator based in Canada and the United States. It is engaged in the development and operation of solar photovoltaic power generation projects in the province of Ontario and the state of New York. The company operates in two principal geographical areas - Canada and United States with a substantial portion of its overall revenue being generated from United States.
About ELUT Elutia Inc.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.